# Canna Decarboxylation and Transdermal RoA

Decarboxylation is a chemical process that converts acidic cannabinoids like THCA and CBDA into their active forms, THC and CBD, respectively. This process is crucial for unlocking the psychoactive and therapeutic properties of cannabis. However, when it comes to transdermal or dermal delivery systems, decarboxylation does not directly affect the mechanism of delivery but rather influences the form and efficacy of the cannabinoids being delivered.

### **Impact on Transdermal and Dermal Delivery**

1. **Activation of Cannabinoids**: Decarboxylation is necessary to activate cannabinoids, which enhances their therapeutic potential. For transdermal and dermal applications, active cannabinoids like THC and CBD are more effective in interacting with the skin's endocannabinoid system\[4\].

2. **Lipophilicity**: Both decarboxylated and non-decarboxylated cannabinoids are lipophilic, meaning they have an affinity for lipid environments. This property is beneficial for crossing the lipid-rich stratum corneum of the skin, although it presents challenges for penetrating deeper aqueous layers\[1\]\[2\].

3. **Formulation Challenges**: The physicochemical properties of cannabinoids, such as their lipophilicity and molecular weight, pose challenges for transdermal delivery. Techniques like nano-encapsulation, use of penetration enhancers, and microemulsions are employed to improve skin permeability and enhance delivery efficacy\[2\]\[6\].

4. **Therapeutic Efficacy**: Decarboxylated cannabinoids are more potent and can provide more pronounced therapeutic effects when delivered transdermally, as they are in their active form. This is particularly relevant for conditions like pain and inflammation, where active cannabinoids can modulate the skin's endocannabinoid system effectively\[5\]\[6\].

Overall, while decarboxylation is essential for activating cannabinoids, the primary challenges in transdermal or dermal delivery lie in overcoming the skin's barrier properties to ensure effective absorption and therapeutic action.

Sources
\[1\] Cannabinoid Formulations and Delivery Systems - NCBI <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417625/>
\[2\] The Skin and Natural Cannabinoidsâ€“Topical and Transdermal ... <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386449/>
\[3\] Cannabis-Based Products for the Treatment of Skin Inflammatory ... <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878527/>
\[4\] Decarboxylation: How to Decarb Weed Step by Step <https://leafwell.com/blog/decarboxylation>
\[5\] Skin applications of cannabidiol: sources, effects, delivery systems ... <https://link.springer.com/article/10.1007/s11101-023-09860-5>
\[6\] The Transdermal Delivery of Therapeutic Cannabinoids - PMC - NCBI <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876728/>
\[7\] Recent advances in transdermal drug delivery systems: a review <https://biomaterialsres.biomedcentral.com/articles/10.1186/s40824-021-00226-6>